Welcome to Keystone Clinical Studies

What is our Mission?

Our Mission is to improve lives of the patient community by helping to bring the most effective new medications to the market.

What do we do?

We test the Safety and Efficacy of investigational medications (Phase 2 to Phase 4 Trials) being developed by Pharmaceutical Sponsors to treat diseases of the Central Nervous System (CNS).

Why do we need new medications?

We conduct research studies for treating Alzheimer’s disease, Generalized Anxiety Disorder, Major Depression, Bipolar Disorder, and Schizophrenia.

These are disorders for which there is no ‘cure’; also, a significant proportion of patients are ‘treatment resistant.’

Therefore, new medications are urgently needed to improve quality of life & alleviate symptoms, increase efficacy for more people, reduce the intensity and frequency of occurrences, reduce side effects of current medications.

A prime example is Alzheimer’s Disease, a serious and debilitating brain disorder, which has no cure at the present time. We are working on a series of clinical trials, which we hope will pave the path to finding a cure in the future.

Why do we need Clinical Trials?

Pharmaceutical companies (called Sponsors) who are engaged in developing new medications start with extensive laboratory testing in animals and human cells. If successful, they send data to the FDA for approval to continue testing on human subjects. The Food and Drug Administration (FDA) of the US Government requires Pharmaceutical Sponsors to conduct clinical trials, before they can approve new prescription drugs for sale in the US.

Without this key step (conducting successful clinical trials with human subjects), we will not be able to bring new medications to the patient (consumer). Clinical trials are imperative for the process of improving treatment outcomes for millions of patients suffering from chronic or life-threatening conditions.